Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials. [electronic resource]
Producer: 20170209Description: 146-155 p. digitalISSN:- 1538-3598
- Calcimimetic Agents -- administration & dosage
- Calcium -- blood
- Double-Blind Method
- Female
- Fibroblast Growth Factor-23
- Fibroblast Growth Factors -- blood
- Humans
- Hyperparathyroidism, Secondary -- blood
- Infusions, Intravenous -- methods
- Male
- Middle Aged
- Parathyroid Hormone -- blood
- Peptides -- administration & dosage
- Placebo Effect
- Renal Dialysis
- Renal Insufficiency, Chronic -- complications
- Time Factors
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.